HeartSciences Inc. (HSCS) Stock Score, Valuation & Financial Research
HeartSciences Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 19/100.
Quick answer for HSCS
HeartSciences Inc. currently has a Wall Street Score of 19/100. The stored market price is $3.39. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is -16.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What HeartSciences Inc. does
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Te
HSCS financial snapshot
- Wall Street Score:
- 19/100
- Current price:
- $3.39
- Market capitalization:
- $7.3M
- Revenue:
- $4K
- Net income:
- $-9.1M
- Free cash flow:
- $-7.5M
- Cash:
- $1.66B
- Total debt:
- $3.9M
- EPS:
- -3.48
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 0/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-7.5M, showing cash burn in the current stored period.
- The balance sheet shows $1.66B of cash versus $3.9M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is -16.5 points: HSCS decreased 16.5 points because Revenue declined by 40 points, Asset declined by 30.6 points, Moat declined by 50 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research HSCS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.